Saeli Thomas Louis's Form 4 filing
Ultralife Corp (ULBI) · filed May 3, 2022
- Accession no.
- 0001437749-22-010637
- Filed
- May 3, 2022
- Trade date
- May 3, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $48.9K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Saeli Thomas LouisCIK 0001490099 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 3, 2022 | Common Stock; $.10 par value | PPurchaseAcquired | +10,000 | $4.89F1 | +$48,900 | 70,446 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. The shares were purchased in two transactions of 5,000 shares each at $4.87 and $4.90.
Referenced by the price of 1 transaction in Table I.